Medicare Enrolled
Dr. Mahan Ostadian, D.O
Anesthesiology · Austin, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ostadian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ostadian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ostadian
Dr. Mahan Ostadian is an anesthesiology specialist in Austin, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Ostadian performed 2,951 Medicare services across 1,480 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ostadian received a total of $33,251 from 64 pharmaceutical and/or device companies across 1468 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ostadian is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 4% volume in TX
$33,251 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,951
Medicare services
Top 4% in TX for anesthesiology
1,480
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~174 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
829 | $88 | $552 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
302 | $12 | $100 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
262 | $240 | $700 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
220 | $0 | $3 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
174 | $153 | $700 |
| Remote therapeutic monitoring, additional 20 minutes This service covers the physician's time for managing remote therapeutic monitoring data beyond the initial monthly allotment. It applies for each additional 20-minute increment used within a calendar month. |
145 | $30 | $60 |
| Remote therapeutic monitoring, first 20 minutes Physician management of remote therapeutic monitoring data for the first 20 minutes per calendar month. |
129 | $37 | $75 |
| Musculoskeletal remote monitoring device supply, 30 days A device supply that records and transmits data for remote monitoring of the musculoskeletal system over a 30-day period. |
96 | $36 | $80 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
88 | $116 | $832 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
74 | $53 | $377 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
68 | $149 | $3,577 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
65 | $48 | $1,486 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
49 | $101 | $2,801 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
44 | $10 | $425 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
37 | $56 | $543 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
37 | $99 | $2,542 |
| Remote therapy monitoring setup and education This service involves setting up equipment and providing patient education for the remote monitoring of therapy. |
34 | $13 | $30 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
30 | $77 | $3,133 |
| Spinal neurostimulator electrode insertion A procedure to place an electrode array into the spine through the skin. The electrode is used to deliver electrical stimulation to the nervous system. |
30 | $223 | $13,435 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
30 | $57 | $1,319 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
28 | $110 | $2,730 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
26 | $65 | $1,371 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
25 | $139 | $3,450 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
23 | $51 | $1,560 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
22 | $82 | $2,100 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
22 | $68 | $2,070 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
17 | $40 | $810 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
16 | $90 | $832 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
15 | $68 | $275 |
| Electronic analysis of implanted neurostimulator with complex programming This procedure involves the electronic evaluation of an implanted neurostimulator generator. It includes complex programming of spinal cord or peripheral nerve stimulators. |
14 | $31 | $480 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$33,251
Total received (2018-2024)
Avg $4,750/year across 7 years
Top 1% in TX for anesthesiology
64
Companies
1,468
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,719 (92.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,532 (7.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,929
2023
$3,226
2022
$5,498
2021
$4,709
2020
$3,714
2019
$4,672
2018
$8,502
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$17,114
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$3,048
Relievant Medsystems, Inc.
$1,499
SI-BONE, Inc.
$1,018
BOSTON SCIENTIFIC CORPORATION
$919
Amgen Inc.
$810
Collegium Pharmaceutical, Inc.
$728
Teva Pharmaceuticals USA, Inc.
$530
PFIZER INC.
$493
Boston Scientific Corporation
$449
Spinal Simplicity, LLC
$448
Medtronic, Inc.
$415
ARBOR PHARMACEUTICALS, INC.
$342
Zyla Life Sciences
$291
Vertiflex, Inc.
$282
SI-BONE, INC.
$274
Lilly USA, LLC
$248
Biohaven Pharmaceuticals, Inc.
$236
Daiichi Sankyo Inc.
$232
Arbor Pharmaceuticals, Inc.
$231
ABBVIE INC.
$215
Novartis Pharmaceuticals Corporation
$212
Scilex Pharmaceuticals Inc.
$209
AbbVie Inc.
$209
Assertio Therapeutics, Inc.
$194
Almatica Pharma LLC
$178
IBSA Pharma Inc.
$155
Pernix Therapeutics Holdings, Inc.
$152
RedHill Biopharma Inc.
$146
Biohaven Pharmaceutical Holding Company Ltd.
$143
Foundation Fusion Solutions, LLC
$132
SCILEX PHARMACEUTICALS INC.
$126
Egalet US Inc
$122
Stimwave Technologies Incorporated
$122
Takeda Pharmaceuticals U.S.A., Inc.
$97
Vertical Pharmaceuticals, LLC
$96
Allergan, Inc.
$94
Horizon Therapeutics plc
$92
Nevro Corp.
$86
AstraZeneca Pharmaceuticals LP
$67
Zyla Life Sciences, Inc.
$66
SPR Therapeutics, Inc
$59
Purdue Pharma L.P.
$58
Nalu Medical, Inc.
$58
PAINTEQ LLC
$49
Vertos Medical, Inc.
$47
Shionogi Inc
$46
Pacira Pharmaceuticals Incorporated
$43
Averitas Pharma Inc.
$42
Saluda Medical Americas, Inc.
$41
Medtronic USA, Inc.
$41
BioDelivery Sciences International, Inc.
$39
Sentynl Therapeutics, Inc.
$29
Flexion Therapeutics, Inc.
$27
HydroCision, Inc.
$27
Radius Health, Inc.
$22
Bioventus LLC
$18
Zimmer Biomet Holdings, Inc.
$15
McKesson Medical-Surgical, Inc.
$14
GRT US Holding, Inc.
$13
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$13
Baudax Bio Inc.
$12
Bard Access Systems, Inc.
$12
Forte Bio-Pharma LLC
$8
Top 3 companies account for 65.1% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ANJESO · Aimovig · Amitiza · Axium INS DRG IPG · BELBUCA · BUNAVAIL 2.1 mg 30-count box · Belbuca · CFNS StimQ Peripheral Nerve StimulatorSystem · COLOGUARD DNA CAPTURE REAGENTS · Cambia · DRG IPGs · DRG leads · EMGALITY · ETERNA · EXCLAIM · Eon Family of SCS IPGs · Evoke · Exclaim SCS Leads · Exparel · FLECTOR · GELSYN 3 · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · GRALISE · Gel One-Knees · General - Therapies · Gralise · HA MINUTEMAN G3-R · HYSINGLA ER · Horizant · IFUSE IMPLANT · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · Iovera · LICART · LORZONE · LUCEMYRA · LYRICA · Levorphanol · Licart · METHYLPHENIDATE 72 · MOVANTIK · Morphabond ER · Movantik · NAPRELAN · NURTEC ODT · Nalocet · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · No Associated Product · Nucynta · Nucynta ER · OCTRODE · Octrode SCS Leads · Omnia · PAINTEQ · PENNSAID · PROCLAIM · PRODIGY · PROGEL · PROTG · Penta SCS Leads · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · QUTENZA · Qutenza · RELISTOR · RELISTOR ORAL · REYVOW · SCS IPGs · SCS leads · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · SPRINT PNS System · SPRIX · SUPERION · SWIFT-LOCK · SYMPROIC · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · StimQ Peripheral Nerve StimulatorSystem · Superion · Superion ISS · Swift-Lock SCS · Symproic · TENJET · TenJet · Tirosint · Tymlos · UBRELVY · VANTA ADAPTIVESTIM · VECTRIS · VIMOVO · WaveWriter Alpha Prime 16 · XTAMPZA · ZOHYDRO ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for anesthesiology in TX.
Equivalent to $1,127 per 100 Medicare services performed
Geographic Context
Anesthesiologists within 10 mi
250
Per 100K population
19.1
County median income
$97,169
Nearest hospital
ASCENSION SETON NORTHWEST
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ostadian is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX), with low-engagement industry engagement in the top 1% of TX peers, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ostadian experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ostadian performed 829 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ostadian receive payments from pharmaceutical companies?
Yes. Dr. Ostadian received a total of $33,251 from 64 companies across 1,468 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ostadian's costs compare to other anesthesiologists in Austin?
Dr. Ostadian's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ostadian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Anesthesiologists in Austin
Browse anesthesiologists in Austin ranked by procedure volume and transparency data.
Highest volume
Top Anesthesiologists in TX
Anesthesiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Anesthesiologists in TX
Which TX anesthesiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Relievant Medsystems, Inc. Payments to Doctors
See all physicians who received payments from Relievant Medsystems, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology